BioIntelliSense BioButton™ Named Best New Monitoring Solution by MedTech Breakthrough Awards
News provided by
Share this article
Share this article
DENVER, May 6, 2021 /PRNewswire/ -- BioIntelliSense, Inc., a continuous health monitoring and clinical intelligence company, today announced the BioButton™ was named the Best New Monitoring Solution in the fifth annual MedTech Breakthrough Awards program conducted by
MedTech Breakthrough, an independent market intelligence organization that recognizes the top companies, technologies, and products in the global health and medical technology market.
2021 MedTech Breakthrough Award
The BioButton is a coin-sized, disposable medical wearable device for continuous monitoring of temperature, heart rate, and respiratory rate at rest to enable early detection of adverse vital sign trends through its proprietary biosensor technology and advanced analytics. The BioIntelliSense medical grade Data-as-a-Service (DaaS) platform and portfolio of wearable devices, including the flagship FDA-cleared BioSticker™, provides a new standard for Remote Patient Monitoring (RPM), by combining an effortless patient experience with medical grade clinical accuracy.